Identifying recent trends in nanomedicine development

International Journal of Nanotechnology

Volumn 7, Issue 2-3, 2010, Pages 173-186

  Darshan, Shalu ^a   Tyshenko, Michael G ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Diagnostics; Medicine; Nanomedicine; Nanotechnology; Therapeutics

Indexed keywords

DIAGNOSIS; DRUG DELIVERY; MEDICINE; NANOPARTICLES; NANOTECHNOLOGY; PLASMA DIAGNOSTICS;

EMERGING TRENDS; NEW APPLICATIONS; PATENT DATABASE; POTENTIAL UTILITY; RAPID EXPANSION; RESEARCH AND DEVELOPMENT; RESEARCH FIELDS; THERAPEUTICS;

MEDICAL NANOTECHNOLOGY;

EID: 75149154926     PISSN: 14757435     EISSN: None     Source Type: Journal    
DOI: 10.1504/IJNT.2010.031309     Document Type: Article

References (54)

1. Moghimi, S.M., Hunter, A.C. and Murray, J.C. (2005) 'Nanomedicine: current status and future prospects', FASEB J., Vol. 19, No. 3, pp.311-330.
2. European Science Foundation (ESF) (2005) Nanomedicine: An ESF-European Medical Research Councils (EMRC) Forward Look Report, 30 November, available at http://www.esf.org/index.php?eID=tx-ccdamdl-file&p[file]=4466&p[dl]= 1&p[pid]=3728&p[ site]=European%20Science%20Foundation&p[t]= 1220649337&hash=04fba0e37d8bbfe530fb 654f2f50f17d&l=en (accessed on 28 August 2008).
3. Jain, K.K. (2007) 'Applications of nanobiotechnology in clinical diagnostics', Clin. Chem., Vol. 53, No. 11, pp.2002-2009.
4. Morrow, K.J., Bawa, R. and Wei, C. (2007) 'Recent advances in basic and clinical nanomedicine', Med. Clin. N. Am., Vol.91, pp.805-843.
5. Sahoo, S.K., Parveen, S. and Panda, M.S. (2007) 'The present and future of nanotechnology in human health care', Nanomed.: Nanotech. Bio., Med., Vol.3, pp.20-31.
6. Emerich, D.F. and Thanos, C.G. (2007) 'Targeted nanoparticle-based drug delivery and diagnosis', J. Drug Targ., Vol. 15, No. 3, pp.163-183.
7. Couvreur, P. and Vauthier, C. (2006) 'Nanotechnology: intelligent design to treat complex diseases', Pharm. Res., Vol. 23, No. 7, pp.1417-1450.
8. Sawant, R.M., Cohen, M.B., Torchilin, V.P., Rokhlin, O.W. (2008) 'Prostate cancer-specific monoclonal antibody 5D4 significantly enhances the cytotoxicity of doxorubicin-loaded liposomes against target cells in vitro', J. Drug Target, Vol. 16, No. 7, pp.601-604.
9. Lammers, T., Hennink, W.E. and Storm, G. (2008) 'Tumour-targeted nanomedicines: principles and practice', Br. J. Cancer, Vol. 99, No. 3, pp.392-397.
10. Fahmy, T.M., Demento, S.L., Caplan, M.J., Mellman, I. and Saltzman, W.M. (2008) 'Design opportunities for actively targeted nanoparticle vaccines', Nanomed., Vol. 3, No. 3, pp.343-355.
11. Muldoon, L.L., Tratnyek, P.G., Jacobs, P.M., Doolittle, N.D., Christoforidis, G.A., Frank, J.A., Lindau, M., Lockman, P.R., Manninger, S.P., Qiang, Y., Spence, A.M., Stupp, S.I., Zhang, M. and Neuwelt, E.A. (2006) 'Imaging and nanomedicine for diagnosis and therapy in the central nervous system: report of the Eleventh Annual Blood-Brain Barrier Disruption Consortium Meeting', AJNR Am. J. Neuroradiol., Vol. 27, No. 3, pp.715-721.
12. Elder, J.B., Liu, C. and Apuzzo, M.L. (2008) 'Neurosurgery in the realm of 10(-9), part 2: applications of nanotechnology to neurosurgery-present and future', Neurosurgery, Vol. 62, No. 2, pp.269-285.
13. Kumar, S. (2006) 'Nanophthalmology: new frontier in fighting blindness?', Eye, Vol. 20, No. 12, pp.1455-1456.
14. Lanza, G., Winter, P., Cyrus, T., Caruthers, S., Marsh, J., Hughes, M. and Wickline, S. (2006) 'Nanomedicine opportunities in cardiology', Ann. N.Y. Acad. Sci., Vol.1080, pp.451-465.
15. Bhumkar, D.R., Joshi, H.M., Sastry, M. and Pokharkar, V.B. (2007) 'Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin', Pharm. Res., Vol. 24, No. 8, pp.1415-1426.
16. Gupta, A.K., Naregalkar, R.R., Vaidya, V.D. and Gupta, M. (2007) 'Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications', Nanomed., Vol. 2, No. 1, pp.23-39.
17. Barnes, T. and Moots, R. (2007) 'Targeting nanomedicines in the treatment of rheumatoid arthritis: focus on certolizumab pegol', Int. J. Nanomed., Vol. 2, No. 1, pp.3-7.
18. Mahony, O. and Jones, J.R. (2008) 'Porous bioactive nanostructured scaffolds for bone regeneration: a sol-gel solution', Nanomed., Vol. 3, No. 2, pp.233-245.
19. Pek, Y.S., Gao, S., Arshad, M.S., Leck, K.J. and Ying, J.Y. (2008) 'Porous collagen-apatite nanocomposite foams as bone regeneration scaffolds', Biomaterials, 13 August, (epub ahead of print).
20. Streicher, R.M., Schmidt, M. and Fiorito, S. (2007) 'Nanosurfaces and nanostructures for artificial orthopedic implants', Nanomed., Vol. 2, No. 6, pp.861-874.
21. Sanvicens, N. and Marco, M.P. (2008) 'Multifunctional nanoparticles - properties and prospects for their use in human medicine', Trends Biotechnol., Vol. 26, No. 8, pp.425-433.
22. Kubik, T., Bogunia-Kubik, K. and Sugisaka, M. (2005) 'Nanotechnology on duty in medical applications', Curr. Pharm. Biotechnol., Vol. 6, No. 1, pp.17-33.
23. Hullmann, A. (2006) 'The economic development of nanotechnology - an indicators-based analysis', European Commission, DG Research, Unit 'Nano S&T - Convergent Science and Technologies', available at http://cordis.europa.eu/ nanotechnology (accessed on 28 August 2008).
24. Caruthers, S.D., Wickline, S.A. and Lanza, G.M. (2007) 'Nanotechnological applications in medicine', Curr. Opin. Biotechnol., Vol. 18, No. 1, pp.26-30.
25. Angeli, E., Buzio, R., Firpo, G., Magrassi, R., Mussi, V., Repetto, L. and Valbusa, U. (2008) 'Nanotechnology applications in medicine', Tumori, Vol. 94, No. 2, pp.206-215.
26. Dinauer, N., Balthasar, S., Weber, C., Kreuter, J., Langer, K. and von Briesen, H. (2005) 'Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes', Biomaterials, Vol. 26, No. 29, pp.5898-5906.
27. Bai, S., Thomas, C., Rawat, A. and Ahsan, F. (2006) 'Recent progress in dendrimer-based nanocarriers', Crit. Rev. Ther. Drug Carrier Syst., Vol. 23, No. 6, pp.437-495.
28. De Jong, W.H. and Borm, P.J. (2008) 'Drug delivery and nanoparticles: applications and hazards', Int. J. Nanomedicine, Vol. 3, No. 2, pp.133-149.
29. Chan, V.S. (2006) 'Nanomedicine: an unresolved regulatory issue', Regul. Toxicol. Pharmacol., Vol. 46, No. 3, pp.218-224.
30. Lam, C.W., James, J.T., McCluskey, R. and Hunter, R.L. (2004) 'Pulmonary toxicity of singlewall carbon nanotubes in mice 7 and 90 days after intratracheal instillation', Toxicol. Sci., Vol.77, pp.126-134.
31. Lu, B., Xiong, S.B., Yang, H., Yin, X.D. and Chao, R.B. (2006) 'Solid lipid nanoparticles of mitoxantrone for local injection against breast cancer and its lymph node metastases', Eur. J. Pharm. Sci., Vol.28, Nos. 1-2, pp.86-95.
32. Warheit, D.B., Webb, T.R., Sayes, C.M., Colvin, V.L. and Reed, K.L. (2006) 'Pulmonary instillation studies with nanoscale TiO2 rods and dots in rats: toxicity is not dependent upon particle size and surface area', Toxicol. Sci., Vol. 91, No. 1, pp.227-236.
33. Bermudez, E., Mangum, J.B., Asgharian, B., Wong, B.A., Reverdy, E.E., Janszen, D.B., Hext, P.M., Warheit, D.B. and Everitt, J.I. (2002) 'Long-term pulmonary responses of three laboratory rodent species to subchronic inhalation of pigmentary titanium dioxide particles', Toxicol. Sci., Vol. 70, No. 1, pp.86-97.
34. Tyshenko, M.G. (2008) 'Medical nanotechnology using genetic material and the need for precaution in design and risk assessments', Int. J. Nanotech., Vol. 5, No. 1, pp.116-123.
35. Lewinski, N., Colvin, V. and Drezek, R. (2008) 'Cytotoxicity of Nanoparticles', Small, Vol. 4, No. 1, pp.26-49.
36. Hamilton, R.F. Jr., Buford, M.C., Wood, M.B., Arnone, B., Morandi, M. and Holian A. (2007) 'Engineered carbon nanoparticles alter macrophage immune function and initiate airway hyper-responsiveness in the BALB/c mouse model', Nanotoxicol., Vol. 1, No. 2, pp.104-117.
37. Oberdörster, G., Stone, V. and Donaldson, K. (2007) 'Toxicology of nanoparticles: a historical perspective', Nanotoxicol., Vol. 1, No. 1, pp.2-25.
38. Hardman, R. (2006) 'A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors', Environ. Health Persp., Vol. 114, No. 2, pp.165-172.
39. Lam, C., James, J.T., McCluskey, R., Arepalli, S. and Hunter, R.L. (2006) 'A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks', Crit. Rev. Toxicol., Vol.36, pp.189-217.
40. Fischer, H.C. and Chan, W.C.W. (2007) 'Nanotoxicity: the growing need for in vivo study', Curr. Opin. Biotechnol., Vol.18, pp.565-571.
41. Schipper, M.L., Nakayama-Ratchford, N., Davis, C.R., Kam, N.W., Chu, P., Liu, Z., Sun, X., Dai, H. and Gambhir, S.S. (2008) 'A pilot toxicology study of single-walled carbon nanotubes in a small sample of mice', Nat. Nanotechnol., Vol. 3, No. 4, pp.216-221.
42. Liu, Z., Chen, K., Davis, C., Sherlock, S., Cao, Q., Chen, X. and Dai, H. (2008) 'Drug delivery with carbon nanotubes for in vivo cancer treatment', Cancer Res., Vol. 68, No. 16, pp.6652-6660.
43. Sonvico, F., Dubernet, C., Colombo, P. and Couvreur, P. (2005) 'Metallic colloid nanotechnolgy, applications in diagnosis and therapeutics', Curr. Pharm. Des., Vol. 11, No. 16, pp.2095-2105.
44. Rhyner, M.N., Smith, A.M., Gao, X., Mao, H., Yang, L. and Nie, S. (2006) 'Quantum dots and multifunctional nanoparticles: new contrast agents or tumor imaging', Nanomed., Vol. 1, No. 2, pp.209-217.
45. Kim, J.W., Shashkov, E.V., Galanzha, E.I., Kotagiri, N. and Zharov, V.P. (2007) 'Photothermal antimicrobial nanotherapy and nanodiagnostics with self-assembling carbon nanotube clusters', Lasers Surg. Med., Vol. 39, No. 7, pp.622-634.
46. Kobayashi, H. and Brechbiel, M.W. (2004) 'Dendrimer-based nanosized MRI contrast agents', Curr. Pharm. Biotechnol., Vol. 5, No. 6, pp.539-549.
47. Mulder, W.J., Strijkers, G.J., van Tilborg, G.A., Griffioen, A.W. and Nicolay, K. (2006) 'Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging', NMR Biomed., Vol. 19, No. 1, pp.142-164.
48. Allen, M., Bulte, J.W., Liepold, L., Basu, G., Zywicke, H.A., Frank, J.A., Young, M. and Douglas, T. (2005) 'Paramagnetic viral nanoparticles as potential high-relaxivity magnetic resonance contrast agents', Magn. Reson. Med., Vol. 54, No. 4, pp.807-812.
49. Zhang, L., Gu, F.X., Chan, J.M., Wang, A.Z., Langer, R.S. and Farokhzad, O.C. (2008) 'Nanoparticles in medicine: therapeutic applications and developments', Clin. Pharma. Therap., Vol. 83, No. 5, pp.761-769.
50. Al-Jamal, W.T. and Kostarelos, K. (2007) 'Liposome-nanoparticle hybrids for multimodal diagnostic and therapeutic applications', Nanomed., Vol. 2, No. 1, pp.85-98.
51. Khopade, A.J., Khopade, S. and Jain, N.K. (2002) 'Development of haemoglobin aquasomes from spherical hydroxyapatite cores precipitated in the presence of half generation poly(amidoamine) dendrimer', Int. J. Pharm., Vol. 241, No. 1, pp.145-154.
52. Cho, K., Wang, X., Nie, S., Chen, Z.G. and Shin, D.M. (2008) 'Therapeutic nanoparticles for drug delivery in cancer', Clin. Cancer Res., Vol. 14, No. 5, pp.1310-1316.
53. Fischlechner, M., Reibetanz, U., Zaulig, M., Enderlein, D., Romanova, J., Leporatti, S., Moya, S. and Donath, E. (2007) 'Fusion of enveloped virus nanoparticles with polyelectrolyte-supported lipid membranes for the design of bio/nonbio interfaces', Nano Lett., Vol. 7, No. 11, pp.3540-3546.
54. Zhang, Y., Lim, C.T., Ramakrishnan, S. and Huang, Z.M. (2005) 'Recent development of polymer nanofibres for biomedical and biotechnological applications', J. Mater. Sci. Mater. Med., Vol. 16, No. 10, pp.933-946.